I can tell you that financial wise Dr. M has done an outstanding job navigating $AVXL from near bankruptcy while trading on the OTC to cleaning up the reporting and capital structure to uplist and ascend to the top tier of NASDAQ.
Now as far as trial result reporting which is a completely different arena It's my understanding the "odds ratio" method of reporting of the AD was not standard and for the Rett readouts the use of RQBQ AUC and anchored to the CGI were also non-standard.
So either $AVXL is a standard faire bullshit biotech selling worthless paper through the equity financing agreement with LPC, or it's not, that is yet to be determined with the next batch of readouts.
Investment wise I tell the very, very, few people I recommend $AVXL to anticipate it being worthless.
I have always enjoyed integrating T/A with my larger macro economic views to maximize returns. Also, I've been an extensive $AVXL covered call seller and T/A helps me a lot in sorting out the magnitude and time part of the equation.
Looking forward to a troll free zone to chat here.
News 
Market Data 
Discover 
